Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute
AstraZeneca
Pfizer
Centre Hospitalier Departemental Vendee
University of California, San Francisco
University of Wisconsin, Madison
Guerbet
Sanofi
Gilead Sciences
Brigham and Women's Hospital
Takeda
Takeda
AstraZeneca
Johns Hopkins University
Merck Sharp & Dohme LLC
Amgen
Bristol-Myers Squibb
Emory University
University of California, San Francisco
University of California, San Francisco
Universitaire Ziekenhuizen KU Leuven
Merck Sharp & Dohme LLC
Columbia University
Pfizer
Johnson & Johnson Private Limited
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Astellas Pharma Inc
Vanderbilt-Ingram Cancer Center
Bayer
Indivior Inc.
McGill University
LEO Pharma
Assiut University
Emory University
Almirall, S.A.
Novartis
VA Office of Research and Development
Janssen Scientific Affairs, LLC
University Health Network, Toronto
Sirtex Medical
Advanced Accelerator Applications
Sumitomo Pharma Switzerland GmbH
Daiichi Sankyo
AstraZeneca
Pfizer
Astellas Pharma Inc
Astellas Pharma Inc
Astellas Pharma Inc
Astellas Pharma Inc